Full transcript: Pfizer CEO Albert Bourla on "Face the Nation," March 13, 2022
The following is a full transcript of an interview with Pfizer CEO Albert Bourla that aired Sunday, March 13, 2022, on "Face the Nation."
Stay updated with breaking news from Operation Light Speed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The following is a full transcript of an interview with Pfizer CEO Albert Bourla that aired Sunday, March 13, 2022, on "Face the Nation."
Source: Shutterstock While 97% of its sales are in the U.S., HZNP is one of those pharmaceuticals that moved its operations to Ireland for favorable tax status. With a $20 billion market cap, it’s one of the biggest pharma stocks on our list. What’s more, it has a handful of drugs already in the market, earning money. HZNP focuses on rheumatic diseases as well as rare and orphan diseases. The rheumatic diseases like gout, mean long-term therapies as do the rare diseases. And the rare diseases usually only have one or two drugs to treat them, although their patient pool is small.